Correlation Between Scandion Oncology and Spago Nanomedical
Can any of the company-specific risk be diversified away by investing in both Scandion Oncology and Spago Nanomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandion Oncology and Spago Nanomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scandion Oncology AS and Spago Nanomedical AB, you can compare the effects of market volatilities on Scandion Oncology and Spago Nanomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandion Oncology with a short position of Spago Nanomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandion Oncology and Spago Nanomedical.
Diversification Opportunities for Scandion Oncology and Spago Nanomedical
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Scandion and Spago is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Scandion Oncology AS and Spago Nanomedical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spago Nanomedical and Scandion Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandion Oncology AS are associated (or correlated) with Spago Nanomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spago Nanomedical has no effect on the direction of Scandion Oncology i.e., Scandion Oncology and Spago Nanomedical go up and down completely randomly.
Pair Corralation between Scandion Oncology and Spago Nanomedical
Assuming the 90 days trading horizon Scandion Oncology AS is expected to under-perform the Spago Nanomedical. In addition to that, Scandion Oncology is 1.02 times more volatile than Spago Nanomedical AB. It trades about -0.06 of its total potential returns per unit of risk. Spago Nanomedical AB is currently generating about 0.2 per unit of volatility. If you would invest 18.00 in Spago Nanomedical AB on October 29, 2024 and sell it today you would earn a total of 6.00 from holding Spago Nanomedical AB or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scandion Oncology AS vs. Spago Nanomedical AB
Performance |
| Timeline |
| Scandion Oncology |
| Spago Nanomedical |
Scandion Oncology and Spago Nanomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scandion Oncology and Spago Nanomedical
The main advantage of trading using opposite Scandion Oncology and Spago Nanomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandion Oncology position performs unexpectedly, Spago Nanomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spago Nanomedical will offset losses from the drop in Spago Nanomedical's long position.| Scandion Oncology vs. ExpreS2ion Biotech Holding | Scandion Oncology vs. Hansa Biopharma AB | Scandion Oncology vs. Fluoguide AS | Scandion Oncology vs. Saniona AB |
| Spago Nanomedical vs. Scandion Oncology AS | Spago Nanomedical vs. Alligator Bioscience AB | Spago Nanomedical vs. Abliva AB | Spago Nanomedical vs. Ascelia Pharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |